Skip to main content

Midland States Bancorp, Inc.

For the period ended Dec 31, 2024. Filed Jul 1, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Jul 1, 2025

MSBI$32.44+0.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 8. Financial Statements and Supplementary Data

Report of Independent Registered Public Accounting Firm (PCAOB ID 173)60
Consolidated Balance Sheets61
Consolidated Statements of Income62
Consolidated Statements of Comprehensive Income63
Consolidated Statements of Shareholders' Equity64
Consolidated Statements of Cash Flows65
Note 1. Summary of Significant Accounting Policies66
Note 2. Investment Securities76
Note 3. Loans78
Note 4. Premises, Equipment and Leases94
Note 5: Operating Leases - Lessor95
Note 6. Loan Servicing Rights95
Note 7. Goodwill and Intangible Assets96
Note 8. Derivative Instruments97
Note 9. Deposits100
Note 10. FHLB Advances and Other Borrowings101
Note 11. Subordinated Debt102
Note 12. Trust Preferred Debentures102
Note 13. Accumulated Other Comprehensive Income (Loss)104
Note 14. Income Taxes105
Note 15. Retirement Plans107
Note 16. Share-Based Compensation109
Note 17. Preferred Stock110
Note 18. Earnings Per Common Share111
Note 19. Capital Requirements111
Note 20. Fair Value of Financial Instruments113
Note 21. Commitments, Contingencies and Credit Risk117
Note 22. Segment Information118
Note 23. Revenue from Contracts with Customers121
Note 24. Parent Company Only Financial Information122
Note 25. Restatement of Prior Period Financial Statements124
Note 26. Subsequent Events135

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Shareholders and the Board of Directors of Midland States Bancorp, Inc.

Effingham, Illinois

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of Midland Sates Bancorp, Inc. (the "Company") as of December 31, 2024 and 2023, the related consolidated statements of income, comprehensive income, shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2024, and the related notes (collectively referred to as the "financial statements"). We also have audited the Company’s internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control – Integrated Framework: (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2024 in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, because of the effects of the material weaknesses discussed in the following paragraphs, the Company has not maintained, in all material respects, effective internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control – Integrated Framework: (2013) issued by COSO.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. The following material weaknesses have been identified and included in management's report:

The Company did not design and maintain controls to assess the risk of material misstatement with contracts related to non-routine transactions.

The Company did not design and maintain an effective internal control activities for evaluating the accounting and financial reporting related to third-party credit enhancement contracts.

The Company did not design and maintain effective internal controls over loan data, including the activities performed by certain third-party service organizations that perform core lending functions. The loan data control deficiencies affect the allowance for credit losses, loan balances, accrued interest, interest income, servicing fees, and the fair value of the credit enhancement derivative.

We considered these material weaknesses identified above in determining the nature, timing, and extent of audit tests applied in our audit of the 2024 consolidated financial statements, and our opinion on Internal Control over Financial Reporting does not affect our opinion on the financial statements.

Restatement of Previously Issued Financial Statements

As discussed in Note 1 to the consolidated financial statements, the 2023 and 2022 consolidated financial statements have been restated to correct misstatements.

Basis for Opinions

The Company’s management is responsible for these financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

Allowance for Credit Losses on Loans – Qualitative Factors

As described in Notes 1 and 3 to the consolidated financial statements, the Allowance for Credit Losses on Loans (“ACL”) represents the Company’s estimate of amounts that are not expected to be collected over the contractual life of the Company’s held for investment loan portfolio. The estimate of the ACL is based on historical experience, current conditions, and reasonable and supportable forecasts. As of December 31, 2024, the Company’s ACL was $111.2 million, and the provision for credit losses on loans was $119.3 million for the year then ended.

The Company measures expected credit losses by utilizing a probability of default, loss given default, and exposure at default model to estimate the quantitative component of the allowance for credit losses for loans. Management qualitatively adjusts the quantitative model results for risk factors that are not considered within the modeling process but are relevant in assessing the expected credit losses. These qualitative factors are based upon management judgment and current assessment as to the impact of risks related to actual and expected changes in economic and business conditions and developments that affect the collectability of the loan pools, changes in volume and severity of past due financial assets, the volume of non-accrual assets, and the volume and severity of adversely classified or graded assets, changes in the value of the underlying collateral for loans that are non-collateral dependent, and other internal and external factors.

We have identified auditing the qualitative factors as a critical audit matter as management’s determination of the qualitative factors is subjective and involves significant management judgments; and our audit procedures related to certain of the qualitative factors involved a high degree of auditor judgment and required significant audit effort, including the need to involve more experienced audit personnel.

The primary audit procedures we performed to address this critical audit matter included:

Tested the operating effectiveness of the Company’s controls over the:

Review over the appropriateness of the framework for the qualitative factors.

Completeness and accuracy of internal data used in the qualitative factors.

Review over the relevance and reliability of external data used in the qualitative factors.

Mathematical accuracy of the qualitative factors.

Substantive tests included:

Testing the completeness and accuracy of internal data and relevance and reliability of external data used in the qualitative factors

Assessing the appropriateness and reasonableness of the framework developed for the qualitative factors including evaluating management’s judgments as to which factors impacted the qualitative analysis for each portfolio segment.

Performing testing over the accuracy of inputs utilized in the calculation of qualitative factors for each portfolio segment.

Testing the mathematical accuracy of the calculation of the qualitative factors.

Goodwill Impairment Assessment

As described in Notes 1 and 7 to the consolidated financial statements, goodwill is the excess of the purchase price over the fair value of the net assets of the business acquired and is periodically evaluated for impairment. The Company’s goodwill balance was $161.9 million as of December 31, 2024, of which $157.2 million is allocated to the Company’s banking segment.

The Company tests for impairment at least annually or, more frequently, if an event occurs or circumstances change that indicate that the fair value of the reporting unit may be below its carrying amount (triggering event). The Company determined that a triggering event occurred and performed a quantitative assessment of goodwill for the Company’s bank reporting unit as of December 31, 2024. The Company engaged a third-party service provider in performing its quantitative impairment assessment. The Company's impairment assessment estimated fair value using an income approach that incorporated a discounted cash flow model that involves management assumptions based upon internal forecasts.

We identified the auditing of the impairment assessment of goodwill as of December 31, 2024 as a critical audit matter due to the significant management judgments related to determining the fair value of the reporting unit, which in turn led to a high degree of auditor judgment and subjectivity in evaluating the fair value of the reporting unit, specifically the significant assumptions related to the multi-year cash projections that rely on internal forecasts and the discount rate. In addition, we used auditor employed specialists to assist in evaluating the significant assumptions.

The primary audit procedures we performed to address this critical audit matter included:

Tested the operating effectiveness of the Company’s controls over the:

Review for completeness and accuracy of internal data and evaluation of the relevance and reliability of external data used in the impairment assessment.

Review of the reasonableness of the Company’s internal forecasts utilized in the impairment assessment.

Evaluation of the reasonableness of the valuation methodologies and the significant assumptions, including discount rate.

Substantive tests included:

Evaluating the reasonableness of the valuation methodologies used to determine the fair value of the reporting unit.

Testing the completeness and accuracy of internal data, and evaluating the relevance and reliability of external data.

Evaluating the reasonableness of the internal forecasts utilized in the impairment assessment.

Utilization of auditor employed specialists to assist with the evaluation of the appropriateness of the valuation methodologies, reasonableness of the discount rate, and overall reasonableness of the fair value of the reporting unit.

Credit Enhancements Contained Within Third-Party Agreements

The Company has agreements with third parties to originate and service consumer and commercial loans that are included in the Company’s loan portfolio as described in Notes 1 and 3 to the consolidated financial statements. As part of these programs, the third-party provider offered various credit enhancements with respect to loans originated under the programs, including contributions to reserve accounts, yield maintenance and certain other payments. The Company has determined that the borrower payments and credit enhancement payments under the programs should be accounted for on a separate unit of account or gross basis, with loan yields and interest income recorded at the gross borrower loan rate, and credit losses and associated provisions for credit losses recorded on a gross basis over the life of the loans, and with all credit enhancement payments accounted for separately as a credit enhancement derivative. As of December 31, 2024, the Company recorded a credit enhancement asset of $16.8 million, which represents the fair value of the credit enhancement derivative associated with the agreements related to loans recorded on the consolidated balance sheet as of the same date.

We identified auditing the accounting associated with the credit enhancement contained within the third-party agreements as a critical audit matter due to the nature and extent of audit effort required, including the need for individuals with specialized knowledge. Additionally, material weaknesses were identified by the Company related to the accounting and financial reporting associated with the credit enhancement contained within the third-party agreements and its impact on consolidated financial statements.

The primary procedure we performed to address this critical audit matter included engaging our internal specialists to evaluate the third-party agreements and the related accounting treatment.

Crowe LLP

We have served as the Company’s auditor since 2017.

Oakbrook Terrace, Illinois

July 1, 2025

CONSOLIDATED BALANCE SHEETS

December 31,2024December 31, 2023(Restated)
Assets
Cash and due from banks$114,055$134,212
Federal funds sold711849
Cash and cash equivalents114,766135,061
Investment securities available for sale, at fair value1,207,574915,895
Equity securities, at fair value4,7924,501
Loans5,167,5746,103,592
Allowance for credit losses on loans(111,204)(159,319)
Total loans, net5,056,3705,944,273
Loans held for sale344,9473,811
Premises and equipment, net85,71082,814
Other real estate owned4,9419,112
Nonmarketable equity securities33,72343,421
Accrued interest receivable25,32934,133
Loan servicing rights, at lower of cost or fair value17,84220,253
Goodwill161,904161,904
Other intangible assets, net12,10016,108
Company-owned life insurance211,168203,485
Credit enhancement asset16,80415,389
Other assets208,839199,886
Total assets$7,506,809$7,790,046
Liabilities and Shareholders’ Equity
Liabilities:
Deposits:
Noninterest-bearing demand deposits$1,055,564$1,145,395
Interest-bearing deposits5,141,6795,164,134
Total deposits6,197,2436,309,529
Short-term borrowings87,49934,865
Federal Home Loan Bank advances and other borrowings258,000476,000
Subordinated debt77,74993,546
Trust preferred debentures51,20550,616
Accrued interest payable and other liabilities124,266110,377
Total liabilities6,795,9627,074,933
Shareholders’ Equity:
Preferred stock, $2.00 par value; 4,000,000 shares authorized; 115,000 Series A shares, $1,000 per share liquidation preference, issued and outstanding at December 31, 2024 and 2023, respectively110,548110,548
Common stock, $0.01 par value; 40,000,000 shares authorized; 21,494,485 and 21,551,402 shares issued and outstanding at December 31, 2024 and 2023, respectively215216
Capital surplus434,346435,463
Retained earnings247,698245,639
Accumulated other comprehensive loss, net of tax(81,960)(76,753)
Total shareholders’ equity710,847715,113
Total liabilities and shareholders’ equity$7,506,809$7,790,046

CONSOLIDATED STATEMENTS OF INCOME

Years Ended December 31,
20242023(Restated)2022(Restated)
Interest income:
Loans including fees:
Taxable$365,892$378,333$285,577
Tax exempt1,5361,7642,082
Loans held for sale392260404
Investment securities:
Taxable49,76928,65315,801
Tax exempt1,5111,3492,746
Nonmarketable equity securities3,0702,8192,198
Federal funds sold and cash investments3,9583,9223,907
Total interest income426,128417,100312,715
Interest expense:
Deposits160,676136,94736,061
Short-term borrowings1,96068104
Federal Home Loan Bank advances and other borrowings16,49520,7099,335
Subordinated debt5,2715,2667,495
Trust preferred debentures5,3805,2893,025
Total interest expense189,782168,27956,020
Net interest income236,346248,821256,695
Provision for credit losses:
Provision for credit losses on loans119,26282,56075,435
Provision for credit losses on unfunded commitments1,070—1,550
Recapture of other credit losses——(221)
Total provision for credit losses120,33282,56076,764
Net interest income after provision for credit losses116,014166,261179,931
Noninterest income:
Wealth management revenue28,69725,57225,708
Service charges on deposit accounts13,15411,99010,237
Interchange revenue13,95514,30213,879
Residential mortgage banking revenue2,4181,9031,509
Income on company-owned life insurance7,6834,4393,584
Loss on sales of investment securities, net(230)(9,372)(230)
Gain on termination of hedged interest rate swaps——17,531
Impairment on commercial mortgage servicing rights——(1,263)
Credit enhancement income60,99848,19469,976
Other income12,06617,7568,936
Total noninterest income138,741114,784149,867
Noninterest expense:
Salaries and employee benefits93,63993,43890,305
Occupancy and equipment16,78515,98614,842
Data processing28,16026,28624,350
FDIC insurance5,2784,7793,336
Professional services7,8227,0496,907
Marketing3,9263,1583,318
Communications1,3641,7412,382
Loan expense5,9544,2064,586
Loan servicing fees12,86419,18122,750
Amortization of intangible assets4,0084,7585,410
Other real estate owned5,5693335,188
Loss on mortgage servicing rights held for sale——3,250
Impairment on leased assets and surrendered assets7,858——
Other expense14,62812,16811,788
Total noninterest expense207,855193,083198,412
Income before income taxes46,90087,962131,386
Income tax expense8,85626,80731,149
Net income38,04461,155100,237
Preferred dividends8,9138,9133,169
Net income available to common shareholders$29,131$52,242$97,068
Per common share data:
Basic earnings per common share$1.32$2.33$4.29
Diluted earnings per common share$1.32$2.33$4.28
Weighted average common shares outstanding21,731,68922,115,86922,341,498
Weighted average diluted common shares outstanding21,737,95822,124,40222,395,698

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(dollars in thousands)

Years Ended December 31,
20242023(Restated)2022(Restated)
Net income$38,044$61,155$100,237
Other comprehensive (loss) income:
Investment securities available for sale:
Unrealized losses that occurred during the period(9,278)(2,536)(106,927)
Recapture of credit loss expense——(221)
Reclassification adjustment for realized net losses on sales of investment securities included in net income2309,372230
Reclassification adjustment for gains on fair value hedges included in net income(142)——
Income tax effect1,677(1,845)28,876
Change in investment securities available for sale, net of tax(7,513)4,991(78,042)
Cash flow hedges:
Net unrealized derivative losses on cash flow hedges(1,692)(2,452)2,551
Reclassification adjustment for net losses (gains) realized in net income4,8915,264(17,644)
Income tax effect(893)(759)4,101
Change in cash flow hedges, net of tax2,3062,053(10,992)
Other comprehensive (loss) income, net of tax(5,207)7,044(89,034)
Total comprehensive income$32,837$68,199$11,203

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

Preferred stockCommonstockCapitalsurplusRetainedearningsAccumulatedothercomprehensiveincome (loss)Totalshareholders'equity
Balances, December 31, 2021$—$221$445,907$212,472$5,237$663,837
Prior period adjustment from restatement———(63,647)—(63,647)
Balances, January 1, 2022 (Restated)—221445,907148,8255,237600,190
Net income———100,237—100,237
Other comprehensive loss————(89,034)(89,034)
Issuance of preferred stock, net of offering costs110,548————110,548
Common dividends declared ($1.16 per share)———(25,923)—(25,923)
Preferred dividends———(3,169)—(3,169)
Common stock repurchased—(1)(1,108)——(1,109)
Share-based compensation expense——2,211——2,211
Issuance of common stock under employee benefit plans—22,186——2,188
Balances, December 31, 2022 (Restated)$110,548$222$449,196$219,970$(83,797)$696,139
Net income———61,155—61,155
Other comprehensive income————7,0447,044
Common dividends declared ($1.20 per share)———(26,573)—(26,573)
Preferred dividends———(8,913)—(8,913)
Common stock repurchased—(8)(17,890)——(17,898)
Share-based compensation expense——2,489——2,489
Issuance of common stock under employee benefit plans—21,668——1,670
Balances, December 31, 2023 (Restated)$110,548$216$435,463$245,639$(76,753)$715,113
Net income———38,044—38,044
Other comprehensive loss————(5,207)(5,207)
Common dividends declared ($1.24 per share)———(27,072)—(27,072)
Preferred dividends———(8,913)—(8,913)
Common stock repurchased—(2)(5,473)——(5,475)
Share-based compensation expense——3,031——3,031
Issuance of common stock under employee benefit plans—11,325——1,326
Balances, December, 31, 2024$110,548$215$434,346$247,698$(81,960)$710,847

CONSOLIDATED STATEMENTS OF CASH FLOWS

(dollars in thousands)

Years Ended December 31,
20242023(Restated)2022(Restated)
Cash flows from operating activities:
Net income$38,044$61,155$100,237
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses120,33282,56076,764
Depreciation on premises and equipment4,9934,7784,842
Amortization of intangible assets4,0084,7585,410
Amortization of operating lease right-of-use asset1,6571,6351,831
Amortization of loan servicing rights2,4981,5502,294
Share-based compensation expense3,0312,4892,211
Increase in cash surrender value of life insurance(7,683)(4,439)(3,320)
Gain on proceeds from company-owned life insurance——(264)
Investment securities (accretion) amortization, net(6,789)(2,414)2,311
Gain on termination of hedged interest rate swaps——(17,531)
Loss on sales of investment securities, net2309,372230
Gain on repurchase of subordinated debt(231)(676)—
(Gain) loss on sales of other real estate owned(26)(819)118
Impairment on other real estate owned4,866—4,277
Origination of loans held for sale(81,077)(58,953)(134,612)
Proceeds from sales of loans and leases held for sale78,51457,952269,958
Gain on sale of loans held for sale(2,307)(2,395)(844)
Impairment on commercial mortgage servicing rights——1,263
Loss on mortgage servicing rights held for sale——3,250
Impairment on leased assets and surrendered assets7,858——
Net change in operating assets and liabilities:
Accrued interest receivable8,804(4,360)(1,448)
Credit enhancement asset(1,415)(2,376)(18,792)
Other assets(16,783)(24,038)1,213
Accrued expenses and other liabilities18,02227,579(13,579)
Net cash provided by operating activities176,546153,358285,819
Cash flows from investing activities:
Purchases of investment securities available for sale(605,169)(412,799)(192,349)
Proceeds from sales of investment securities available for sale74,116191,733136,403
Maturities and payments on investment securities available for sale233,56374,53185,077
Purchases of equity securities(268)(286)(511)
Proceeds from sales of equity securities—5,148—
Net decrease (increase) in loans346,88372,877(1,216,352)
Proceeds from loans held for sale previously classified as portfolio loans84,28340,899—
Purchases of premises and equipment(6,901)(8,731)(3,470)
Proceeds from sale of premises and equipment37104175
Purchases of nonmarketable equity securities(172,057)(239,597)(24,787)
Proceeds from redemptions of nonmarketable equity securities181,755242,37714,927
Proceeds from sales of other real estate owned4667,5471,453
(Purchases of) proceeds from company-owned life insurance, net—(48,603)1,518
Net cash acquired in acquisitions——60,275
Net cash provided by (used in) investing activities136,708(74,800)(1,137,641)
Cash flows from financing activities:
Net (decrease) increase in deposits(112,286)(55,123)174,210
Net increase (decrease) in short-term borrowings52,634(7,446)(34,492)
Net (decrease) increase in short-term FHLB borrowings(166,000)(174,000)250,000
Proceeds from long-term FHLB borrowings263,000215,000—
Payments made on long-term FHLB borrowings and other borrowings(315,000)(25,000)(100,171)
Payments made on subordinated debt(15,763)(5,845)(40,000)
Proceeds from issuance of preferred stock——110,548
Cash dividends paid on preferred stock(8,913)(8,913)(3,169)
Cash dividends paid on common stock(27,072)(26,573)(25,923)
Common stock repurchased(5,475)(17,898)(1,109)
Proceeds from issuance of common stock under employee benefit plans1,3261,6702,188
Net cash (used in) provided by financing activities(333,549)(104,128)332,082
Net decrease in cash and cash equivalents(20,295)(25,570)(519,740)
Cash and cash equivalents:
Beginning of period135,061160,631680,371
End of period$114,766$135,061$160,631

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.